Biospecifics Technologies Corp Asset Turnover Ratio (BSTC), as of third quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biospecifics Technologies Corp  (NASDAQ: BSTC)
 

Biospecifics Technologies Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Biospecifics Technologies Corp asset turnover ratio, the ability of Biospecifics Technologies Corp's assets to generate revenue in the third quarter 2020, increased sequentially to 0.28 in the third quarter (Sep 30 2020), yet the ratio remained below the average, as BSTC's position remain challenging.

Within sector 197 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2020 compared to the preceding quarter from 2596 to 3380.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSTC Asset Turnover Ratio (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Asset Change 15.87 % 19.55 % 25.76 % 26.54 % 26.64 %
Y / Y Revenue Change 19.21 % -55.91 % 18.94 % 10.9 % 15.6 %
Asset Turnover Ratio (TTM) 0.28 0.27 0.32 0.33 0.34
BSTC's Total Ranking # 3380 # 2596 # 3376 # 3380 # 3374
Seq. Asset Change 2.61 % 0.4 % 5.21 % 6.91 % 5.87 %
Seq. Revenue Change 188.36 % -59.63 % -17.81 % 24.58 % 6.66 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 198
Healthcare Sector # 508
Overall Market # 3380

Asset Turnover Ratio Statistics
High Average Low
6.12 3.83 2.09
(Sep 30 2017)   (Dec 31 2018)




BSTC Company Profile • Back to BSTC Efficiency Comparisons • Compare BSTC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2020 Assets at quarter ending Sep 30 2020
Neurocrine Biosciences Inc   0.73 $ 1,042.010  Millions$ 1,421.535  Millions
Encompass Health Corporation  0.73 $ 4,614.400  Millions$ 6,332.850  Millions
U S Physical Therapy Inc  0.72 $ 427.617  Millions$ 591.139  Millions
Staar Surgical Co  0.72 $ 156.345  Millions$ 216.598  Millions
Irhythm Holdings Inc   0.72 $ 245.691  Millions$ 340.644  Millions
Varian Medical Systems Inc   0.72 $ 3,168.200  Millions$ 4,427.800  Millions
Cardiff Lexington Corporation  0.72 $ 3.694  Millions$ 5.164  Millions
Cryo cell International Inc   0.71 $ 31.577  Millions$ 44.224  Millions
Icu Medical Inc  0.71 $ 1,266.076  Millions$ 1,774.490  Millions
Pediatrix Medical Group Inc   0.71 $ 2,721.131  Millions$ 3,819.400  Millions
American Renal Associates Holdings Inc   0.71 $ 814.098  Millions$ 1,142.684  Millions
Biodelivery Sciences International Inc   0.71 $ 145.940  Millions$ 206.888  Millions
Masimo Corp  0.71 $ 1,096.200  Millions$ 1,554.863  Millions
Tenet Healthcare Corp  0.70 $ 17,531.000  Millions$ 24,902.750  Millions
3m Company  0.70 $ 31,712.000  Millions$ 45,335.000  Millions
Omeros Corporation  0.70 $ 96.598  Millions$ 138.237  Millions
Invo Fertility Inc   0.69 $ 1.169  Millions$ 1.687  Millions
Protalix Biotherapeutics inc   0.69 $ 47.183  Millions$ 68.072  Millions
Trinity Biotech Plc  0.69 $ 90.482  Millions$ 130.566  Millions
Labcorp Holdings Inc   0.69 $ 12,442.100  Millions$ 17,983.375  Millions
Natus Medical Inc  0.69 $ 428.382  Millions$ 621.923  Millions
Camp4 Therapeutics Corporation  0.69 $ 347.553  Millions$ 504.999  Millions
Inogen Inc   0.69 $ 313.426  Millions$ 456.228  Millions
Societal Cdmo Inc   0.69 $ 74.229  Millions$ 108.285  Millions
Meridian Bioscience Inc   0.68 $ 253.667  Millions$ 370.563  Millions
Opiant Pharmaceuticals Inc   0.68 $ 27.370  Millions$ 40.057  Millions
Bruker Corporation  0.68 $ 1,959.900  Millions$ 2,889.050  Millions
Edwards Lifesciences Corporation  0.68 $ 4,368.700  Millions$ 6,447.275  Millions
Haemonetics Corporation  0.67 $ 902.525  Millions$ 1,339.051  Millions
Mannkind Corporation  0.67 $ 62.694  Millions$ 93.100  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.